NCT04988672 OPTIMISER Registry - A Prospective Cohort Study to Describe the OPTIMal Management and Outcomes of PatIents PreSEnting With Acute MyocaRdial Infarction
| NCT ID | NCT04988672 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Luzerner Kantonsspital |
| Condition | Myocardial Infarction |
| Study Type | OBSERVATIONAL |
| Enrollment | 4,000 participants |
| Start Date | 2021-01-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 4,000 participants in total. It began in 2021-01-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the OPTIMISER Registry is to prospectively and retrospectively collect baseline, clinical and procedural data in patients who present with AMI and are treated with PCI as well as prospectively collect the clinical outcome data. Outcomes will be compared in different clinical subgroups. The impact of PCI in AMI in general as well as cardiovascular outcomes after AMI will be assessed.
Eligibility Criteria
Inclusion Criteria: * Subject \>18 years of age * Individuals who are newly diagnosed with AMI or have been diagnosed with AMI (STEMI or NSTEMI) within the last 5 years (since 2016). * Subjects must be willing to sign a patient informed consent (PIC) OR a patient ́s relative/ proxy are willing to provide PIC or patients have signed the General Consent (GK). Exclusion Criteria: * Patient unwilling or unable to provide informed consent * Patients with no ACS/AMI (e.g. Takotsubo cardiomyopathy, acute heart failure not related to AMI)
Contact & Investigator
Florim Cuculi, M.D.
PRINCIPAL INVESTIGATOR
Luzerner Kantonsspital
Frequently Asked Questions
Who can join the NCT04988672 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Myocardial Infarction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04988672 currently recruiting?
Yes, NCT04988672 is actively recruiting participants. Contact the research team at florim.cuculi@luks.ch for enrollment information.
Where is the NCT04988672 trial being conducted?
This trial is being conducted at Lucerne, Switzerland.
Who is sponsoring the NCT04988672 clinical trial?
NCT04988672 is sponsored by Luzerner Kantonsspital. The principal investigator is Florim Cuculi, M.D. at Luzerner Kantonsspital. The trial plans to enroll 4,000 participants.